Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) EBITDA: 2019-2024

Historic EBITDA for IM Cannabis (IMCC) over the last 6 years, with Dec 2024 value amounting to -$9.6 million.

  • IM Cannabis' EBITDA fell 215.68% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.4 million, marking a year-over-year decrease of 40.32%. This contributed to the annual value of -$9.6 million for FY2024, which is 19.91% down from last year.
  • Latest data reveals that IM Cannabis reported EBITDA of -$9.6 million as of FY2024, which was down 19.91% from -$8.0 million recorded in FY2023.
  • In the past 5 years, IM Cannabis' EBITDA registered a high of -$8.0 million during FY2023, and its lowest value of -$23.7 million during FY2022.
  • For the 3-year period, IM Cannabis' EBITDA averaged around -$13.8 million, with its median value being -$9.6 million (2024).
  • Its EBITDA has fluctuated over the past 5 years, first tumbled by 390.51% in 2020, then spiked by 66.04% in 2023.
  • Yearly analysis of 5 years shows IM Cannabis' EBITDA stood at -$20.7 million in 2020, then surged by 34.08% to -$13.7 million in 2021, then crashed by 73.48% to -$23.7 million in 2022, then spiked by 66.04% to -$8.0 million in 2023, then fell by 19.91% to -$9.6 million in 2024.